Chiara Balestrieri

6PUBLICATIONS
96CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyGene expression (incl. microarray and other genome-wide approaches)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 06, 2026
DPY30 Is an Epigenetic Decoupler Linking Replication Stress to Immunoediting in Pancreatic Cancer.

Francesca Citron, Luca Cecchetto, Elisabetta Granato

|Jan 08, 2026
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength.

Martina Spiga, Alessia Potenza, Zulma Magnani

|Nov 01, 2024
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancer.

Francesca Citron, I-Lin Ho, Chiara Balestrieri

|May 02, 2024
Scalable integration of multiomic single-cell data using generative adversarial networks.

Valentina Giansanti, Francesca Giannese, Oronza A Botrugno

|Dec 01, 2023
Harnessing T cell exhaustion and trogocytosis to isolate patient-derived tumor-specific TCR.

Francesco Manfredi, Lorena Stasi, Silvia Buonanno

|Sep 16, 2021
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis.

Edoardo Del Poggetto, I-Lin Ho, Chiara Balestrieri

Pageof 1